Lyondellbasell Industries NV

This proposal asks shareholders to grant a formal discharge (a Dutch-law mechanism) releasing the Company’s executive and non-executive directors from liability for actions and decisions taken in the 2025 fiscal year, subject to the statutory exceptions (for example, bankruptcy-related liability or matters not disclosed to shareholders). Management seeks this vote as a routine element of Dutch corporate governance that provides legal closure for the prior fiscal year and is customary for Dutch-incorporated companies; it does not create new rights but confirms that disclosed actions of the board and management are accepted by shareholders. The context includes a challenging 2025 operating environment, portfolio repositioning actions (including refinery exit and European divestitures), and significant one-time restructuring and impairment items disclosed in the financial statements; the discharge vote reflects the board’s view that it acted appropriately in overseeing those actions. A vote FOR is recommended by the Board and is framed as consistent with the shareholders’ prior ability to discuss corporate matters at the annual meeting; a vote AGAINST would signal disagreement with the board’s stewardship for 2025 and could complicate governance relations. From a legal perspective, a discharge in the Dutch context does not bar claims based on matters not disclosed or bankruptcy-related claims, so the scope is limited. Investors should weigh the company’s disclosures (including the Dutch statutory annual accounts and narrative of strategic and portfolio actions) and their view on whether the Board exercised appropriate oversight in 2025. Given management’s recommendation and the information provided in the proxy (including disclosures of impairments, portfolio transactions, and the Cash Improvement Plan), a FOR vote is the Board-endorsed governance closure for the year. The proposal is procedural but meaningful in the Dutch legal context; it forms part of the annual accountability cycle between shareholders and directors and is typically approved when shareholders accept management’s disclosures and explanations.

This proposal requests shareholder approval to adopt the Company’s 2025 Dutch statutory annual accounts, prepared under IFRS and Dutch law. Management is seeking formal adoption because Dutch corporate law and the Company’s Articles of Association require shareholders to adopt the statutory accounts at the annual meeting; adoption is the legal acceptance of the financial statements for the fiscal year. The proxy includes supplemental disclosure about dividends (aggregate $4.80 per share paid from the 2025 statutory accounts and a long history of dividend payments) and a discussion of the dividend policy—useful context for investors assessing capital allocation. Adoption signals shareholder acceptance of management’s accounting for the significant events in 2025, including asset write-downs, impairments, and portfolio actions (e.g., refinery exit and European divestitures) disclosed elsewhere in the proxy and annual report. From a governance perspective, adoption is often coupled with the discharge vote and the auditor appointment; investors should consider that adopting the accounts does not foreclose later legal claims for undisclosed matters or bankruptcy-related liability. The Board recommends FOR to confirm shareholders’ acceptance of the reported results and to allow the statutory accounts to be filed and used for Dutch legal and tax purposes. For sophisticated investors, the vote is both a legal formality in a Dutch corporate governance framework and a signal of confidence (or lack thereof) in the Company’s 2025 financial reporting and capital allocation decisions. Given the Company’s transparent disclosures about one-time items and the availability of the full statutory accounts for review, the Board’s recommendation reflects their view that the accounts fairly present the Company’s 2025 financial position and results.

This advisory proposal asks shareholders to approve the Company’s 2025 executive compensation disclosure (the CD&A, summary tables, and related disclosures) on a non-binding basis. Management seeks endorsement to validate its pay-for-performance program, which it says ties a significant portion of executive pay to financial, safety, sustainability, and value creation metrics and emphasizes long-term incentives (PSUs and RSUs). The proxy highlights that the program had strong prior shareholder support (approximately 96% in 2025) and that the C&TD Committee uses independent consultants, benchmarking to peers, and a combination of annual and multi-year performance metrics to set awards. The 2025 context includes challenging market conditions, impairments, and a Cash Improvement Plan; the Company reports 67% STI payout and a 25% payout on 2023 PSUs reflective of TSR and FCF outcomes, showing alignment between realized performance and realized pay. Management’s recommendation to vote FOR is grounded in (i) the committee’s view that compensation decisions were reasonable given 2025 performance, (ii) practices such as clawbacks, share ownership guidelines, minimum vesting, and double-trigger change-in-control protections, and (iii) ongoing shareholder engagement. For sophisticated investors, the advisory vote is a signal of support for governance and compensation design; while non-binding, the Board and C&TD Committee state they will consider results in future decisions. Key contested areas for analysis include the stringency of performance metrics and adjustments to EBITDA targets in downcycles; investors should assess whether the disclosed metrics and actual payouts align sufficiently with their view of performance and risk-taking incentives. Overall, management frames the proposal as a reaffirmation of alignment between pay and long-term shareholder value creation.

This proposal seeks shareholder authorization for the Board to repurchase up to 10% of the company’s issued share capital over an 18-month period, giving management broad execution flexibility (open market, negotiated purchases, tenders, accelerated repurchases) and price caps (up to 110% of market). Management frames the request as a capital-allocation tool to return excess cash when appropriate; the authorization replaces the prior repurchase authority and is a routine mechanism under Dutch law requiring shareholder approval. The proxy highlights that as of April 1, 2026 no repurchases had been made under the previous authorization and notes the Board will consider liquidity, market conditions, and other factors when deciding repurchases. For investors, the proposal represents optionality: share buybacks can be value-accretive when shares are undervalued and capital is otherwise surplus, but they also consume liquidity that could be used for deleveraging or investment—an important consideration given the Company’s recent impairments and the ongoing portfolio optimization efforts. The Board’s recommendation to vote FOR emphasizes preserving flexibility while maintaining an investment-grade balance sheet; the Finance Committee will oversee execution. Analysts should evaluate this request in the context of the Company’s cash generation, dividend policy, upcoming maturities, and stated capital allocation priorities (dividends plus repurchases and strategic investment). The authorization’s practical limits (10% cap, explicit pricing rules, and expiration) help define the scope and governance of buybacks. Overall, the proposal is a standard but meaningful capital allocation lever; a FOR vote preserves management’s ability to opportunistically repurchase shares subject to fiduciary oversight.

This proposal asks shareholders to authorize cancellation of all or part of the Company’s treasury shares (approximately 17.7 million shares as of April 1, 2026), giving the Board discretion to determine the number and timing of cancellations, subject to Dutch statutory procedures and a two-month filing/notification period. Management seeks this authority to provide flexibility in capital structure management following repurchases and to reduce share count if cancellation is deemed beneficial; alternatively, treasury shares could be deployed for compensation plans or other corporate purposes if not cancelled. In the Dutch legal framework, shareholder approval is required for cancellation, and the proxy explains the mechanics and statutory limits (treasury holdings cannot exceed 50% of issued capital). For investors, cancellation is effectively a method to make repurchases permanent and potentially increase per-share metrics; however, cancellation reduces the pool available for future equity grants and must be weighed against long-term dilution management. The Board’s FOR recommendation reflects a desire to preserve strategic options following share repurchases authorized under Item 7. Analysts should evaluate this request in the context of the Company’s cash position, recent capital returns (dividends and repurchases), and ongoing LTIP usage, since cancellation can change dilution dynamics. The proposed language leaves specific cancellation decisions to the Board, which may execute in tranches, so continued shareholder oversight and disclosure of any cancellations will be important for governance transparency. Overall, the proposal is a routine corporate housekeeping item in the Dutch context but has meaningful capital structure implications when exercised.

This proposal seeks shareholder approval to amend and restate the LTIP to add 8,000,000 shares to the existing reserve and to add a per-annum $2 million grant cap for non-employee directors (grant-date fair value), with shareholder authority to issue the added shares and exclude pre-emptive rights for five years. Management argues the increase is needed because recent industry volatility could otherwise leave insufficient shares for competitive long-term incentive (LTI) grants used for retention, recruitment, and alignment with shareholders; the C&TD Committee consulted an independent advisor prior to recommending the change. The proxy provides burn-rate and potential dilution metrics (three-year average burn rate ~0.44% and potential dilution after the increase ~4.91%), and commits to plan-level governance features such as minimum vesting, no liberal share recycling, double-trigger change-in-control treatment, and no repricing without shareholder approval—features intended to mitigate dilution and align with best practices. For investors, the principal considerations are whether the additional authorization is sized appropriately relative to historical grant practices and whether the plan’s governance provisions sufficiently limit dilution and protect shareholders. The five-year authority to issue shares and exclude pre-emptive rights is common for a Netherlands-incorporated company but warrants scrutiny because it permits the Board to issue shares without preemptive subscription rights during that period. The Board’s FOR recommendation rests on the need to maintain competitive equity programs and a controlled, limited increase rather than ongoing evergreen issuance. Sophisticated investors should evaluate the proposal in light of the Company’s stated burn rate, current outstanding awards, expected grant needs for 2026–2027, and the company’s capital allocation priorities; the disclosed metrics and safeguards provide transparency to inform that assessment. Overall, the proposal balances operational needs for LTI grants with explicit limits and governance protections; a FOR vote preserves the company’s ability to implement incentive plans within the disclosed parameters.